-
1
-
-
70349240414
-
Chronic hepatitis B: update 2009
-
Lok, A.S., McMahon, B.J., Chronic hepatitis B: update 2009. Hepatology 50 (2009), 661–662.
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
2
-
-
51049107683
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
-
Liaw, Y.F., Leung, N., Kao, J.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2 (2008), 263–283.
-
(2008)
Hepatol Int
, vol.2
, pp. 263-283
-
-
Liaw, Y.F.1
Leung, N.2
Kao, J.H.3
-
3
-
-
58149296156
-
EASL clinical practice guidelines: management of chronic hepatitis
-
European Association for the Study of the Liver, EASL clinical practice guidelines: management of chronic hepatitis. J Hepatol 50 (2009), 227–242.
-
(2009)
J Hepatol
, vol.50
, pp. 227-242
-
-
European Association for the Study of the Liver1
-
4
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
Liaw, Y.F., Sung, J.J., Chow, W.C., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004), 1521–1531.
-
(2004)
N Engl J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
-
5
-
-
79251496109
-
Review article: chronic hepatitis B–anti-viral or immunomodulatory therapy?
-
Rijckborst, V., Sonneveld, M.J., Janssen, H., Review article: chronic hepatitis B–anti-viral or immunomodulatory therapy?. Aliment Pharmacol Ther 33 (2011), 501–513.
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 501-513
-
-
Rijckborst, V.1
Sonneveld, M.J.2
Janssen, H.3
-
6
-
-
66149190942
-
Side effects of long-term oral antiviral therapy for hepatitis B
-
Fontana, R.J., Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology(5), 2009, S185–S195.
-
(2009)
Hepatology
, Issue.5
, pp. S185-S195
-
-
Fontana, R.J.1
-
7
-
-
67649224111
-
Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia
-
Liaw, Y.F., Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 51 (2009), 403–410.
-
(2009)
J Hepatol
, vol.51
, pp. 403-410
-
-
Liaw, Y.F.1
-
8
-
-
34247478067
-
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome
-
Andreani, T., Serfaty, L., Mohand, D., et al. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. Clin Gastroenterol Hepatol 5 (2007), 636–641.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 636-641
-
-
Andreani, T.1
Serfaty, L.2
Mohand, D.3
-
9
-
-
42949107039
-
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
-
Kumar, M., Sarin, S.K., Hissar, S., et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 134 (2008), 1376–1384.
-
(2008)
Gastroenterology
, vol.134
, pp. 1376-1384
-
-
Kumar, M.1
Sarin, S.K.2
Hissar, S.3
-
10
-
-
34547488366
-
Risk and predictors of mortality associated with chronic hepatitis B infection
-
Iloeje, U.H., Yang, H.I., Jen, C.L., et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 5 (2007), 921–931.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 921-931
-
-
Iloeje, U.H.1
Yang, H.I.2
Jen, C.L.3
-
11
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
Chen, C.J., Yang, H.I., Su, J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006), 65–73.
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
-
12
-
-
33644858331
-
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
-
Iloeje, U.H., Yang, H.I., Su, J., et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 (2006), 678–686.
-
(2006)
Gastroenterology
, vol.130
, pp. 678-686
-
-
Iloeje, U.H.1
Yang, H.I.2
Su, J.3
-
13
-
-
79951649293
-
Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B
-
Croagh, C.M., Bell, S.J., Slavin, J., et al. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Liver Int 30 (2010), 1085–1086.
-
(2010)
Liver Int
, vol.30
, pp. 1085-1086
-
-
Croagh, C.M.1
Bell, S.J.2
Slavin, J.3
-
14
-
-
77749308564
-
Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase
-
Gui, H.L., Wang, H., Yang, Y.H., et al. Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase. J Viral Hepat 17 (2010), 44–50.
-
(2010)
J Viral Hepat
, vol.17
, pp. 44-50
-
-
Gui, H.L.1
Wang, H.2
Yang, Y.H.3
-
15
-
-
0021858507
-
Natural history of chronic hepatitis B virusinfection in Taiwan: studies of hepatitis B virus DNA in serum
-
Chu, C.M., Karayiannis, P., Fowler, M.J.F., et al. Natural history of chronic hepatitis B virusinfection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5 (1985), 431–434.
-
(1985)
Hepatology
, vol.5
, pp. 431-434
-
-
Chu, C.M.1
Karayiannis, P.2
Fowler, M.J.F.3
-
16
-
-
34548303664
-
Natural history and disease progression in Chinese chronic hepatitis B patients in immunetolerant phase
-
Hui, C.K., Leung, N., Yuen, S.T., et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immunetolerant phase. Hepatology 46 (2007), 395–401.
-
(2007)
Hepatology
, vol.46
, pp. 395-401
-
-
Hui, C.K.1
Leung, N.2
Yuen, S.T.3
-
17
-
-
57249086243
-
Need to strictly define hepatitis B virus (HBV) immunotolerant patients to avoid unnecessary liver biopsy
-
Andreani, T., Serfaty, L., Poupon, R., et al. Need to strictly define hepatitis B virus (HBV) immunotolerant patients to avoid unnecessary liver biopsy. Gastroenterology 135 (2008), 2155–2156.
-
(2008)
Gastroenterology
, vol.135
, pp. 2155-2156
-
-
Andreani, T.1
Serfaty, L.2
Poupon, R.3
-
18
-
-
67650957714
-
Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease
-
Kumar, M., Sarin, S.K., Hepatitis B virus immunotolerant patients: need to differentiate patients with or without liver disease. Gastroenterology 137 (2009), 742–743.
-
(2009)
Gastroenterology
, vol.137
, pp. 742-743
-
-
Kumar, M.1
Sarin, S.K.2
-
19
-
-
0037008087
-
Updated definitions of healthy ranges for serum alanine aminotransferase levels
-
Prati, D., Taioli, E., Zanella, A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137 (2002), 1–10.
-
(2002)
Ann Intern Med
, vol.137
, pp. 1-10
-
-
Prati, D.1
Taioli, E.2
Zanella, A.3
-
20
-
-
58849110389
-
Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients
-
Wong, G.L., Wong, V.W., Choi, P.C., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol 7 (2009), 227–233.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 227-233
-
-
Wong, G.L.1
Wong, V.W.2
Choi, P.C.3
-
21
-
-
33846983919
-
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
-
Chu, C.M., Liaw, Y.F., Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 14 (2007), 147–152.
-
(2007)
J Viral Hepat
, vol.14
, pp. 147-152
-
-
Chu, C.M.1
Liaw, Y.F.2
-
22
-
-
27444441182
-
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
-
Yuen, M.F., Yuan, H.J., Wong, D.K., et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54 (2005), 1610–1614.
-
(2005)
Gut
, vol.54
, pp. 1610-1614
-
-
Yuen, M.F.1
Yuan, H.J.2
Wong, D.K.3
-
23
-
-
67649199520
-
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
-
Tai, D.I., Lin, S.M., Sheen, I.S., Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 49 (2009), 1859–1867.
-
(2009)
Hepatology
, vol.49
, pp. 1859-1867
-
-
Tai, D.I.1
Lin, S.M.2
Sheen, I.S.3
-
24
-
-
56149086622
-
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
-
Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?. Hepatology 48 (2008), 1451–1459.
-
(2008)
Hepatology
, vol.48
, pp. 1451-1459
-
-
Papatheodoridis, G.V.1
Manesis, E.K.2
Manolakopoulos, S.3
-
25
-
-
10744221863
-
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis
-
Myers, R.P., Tainturier, M.H., Ratziu, V., et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis. J Hepatol 39 (2003), 222–230.
-
(2003)
J Hepatol
, vol.39
, pp. 222-230
-
-
Myers, R.P.1
Tainturier, M.H.2
Ratziu, V.3
-
26
-
-
84984569437
-
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
-
Lin, C.L., Liao, L.Y., Liu, C.J., Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 45 (2007), 1193–1198.
-
(2007)
Hepatology
, vol.45
, pp. 1193-1198
-
-
Lin, C.L.1
Liao, L.Y.2
Liu, C.J.3
-
27
-
-
35748984106
-
The clinical significance of persistently normal ALT in chronic hepatitis B infection
-
Lai, M., Hyatt, B.J., Nasser, I., Curry, M., Afdhal, N.H., The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 47 (2007), 760–767.
-
(2007)
J Hepatol
, vol.47
, pp. 760-767
-
-
Lai, M.1
Hyatt, B.J.2
Nasser, I.3
Curry, M.4
Afdhal, N.H.5
-
28
-
-
42949096013
-
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels
-
Tsang, P.S., Trinh, H., Garcia, R.T., Phan, J.T., Ha, N.B., Nguyen, H., et al. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol 6 (2008), 569–574.
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 569-574
-
-
Tsang, P.S.1
Trinh, H.2
Garcia, R.T.3
Phan, J.T.4
Ha, N.B.5
Nguyen, H.6
-
29
-
-
77950609092
-
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
-
Wu, I.C., Lai, C.L., Han, S.H., Han, K.H., Gordon, S.C., Chao, Y.C., et al. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology 51 (2010), 1185–1189.
-
(2010)
Hepatology
, vol.51
, pp. 1185-1189
-
-
Wu, I.C.1
Lai, C.L.2
Han, S.H.3
Han, K.H.4
Gordon, S.C.5
Chao, Y.C.6
-
30
-
-
60349102372
-
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
-
Park, J.Y., Park, Y.N., Kim, D.Y., et al. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. J Viral Hepat 15 (2008), 615–621.
-
(2008)
J Viral Hepat
, vol.15
, pp. 615-621
-
-
Park, J.Y.1
Park, Y.N.2
Kim, D.Y.3
-
31
-
-
34848825946
-
Presence of biopsy-proven histologic damage (necroinflamamtion and fibrosis) is common even when ALT is less than 2 X ULN in patients with chronic hepatitis
-
Terrault, N., Kim, R., Schalm, S., et al. Presence of biopsy-proven histologic damage (necroinflamamtion and fibrosis) is common even when ALT is less than 2 X ULN in patients with chronic hepatitis. J Hepatol, 46(suppl 1), 2007, S184.
-
(2007)
J Hepatol
, vol.46
, pp. S184
-
-
Terrault, N.1
Kim, R.2
Schalm, S.3
-
32
-
-
77952742728
-
Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B
-
Jeng, W.J., Sheen, I.S., Liaw, Y.F., Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol 8 (2010), 541–545.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 541-545
-
-
Jeng, W.J.1
Sheen, I.S.2
Liaw, Y.F.3
-
33
-
-
0037371501
-
A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy
-
Yuen, M.F., Yuan, H.J., Hui, C.K., et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 52 (2003), 416–419.
-
(2003)
Gut
, vol.52
, pp. 416-419
-
-
Yuen, M.F.1
Yuan, H.J.2
Hui, C.K.3
-
34
-
-
0023219186
-
Relation of the hepatitis B virus carrier state to hepatocellular carcinoma
-
Popper, H., Shafritz, D.A., Hoofnagle, J.H., Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 7 (1987), 764–772.
-
(1987)
Hepatology
, vol.7
, pp. 764-772
-
-
Popper, H.1
Shafritz, D.A.2
Hoofnagle, J.H.3
-
35
-
-
0036110833
-
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
-
Martinot-Peignoux, M., Boyer, N., Colombat, M., et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36 (2002), 543–546.
-
(2002)
J Hepatol
, vol.36
, pp. 543-546
-
-
Martinot-Peignoux, M.1
Boyer, N.2
Colombat, M.3
-
36
-
-
55549091704
-
The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study
-
Zacharakis, G., Koskinas, J., Kotsiou, S., et al. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study. J Hepatol 49 (2008), 884–891.
-
(2008)
J Hepatol
, vol.49
, pp. 884-891
-
-
Zacharakis, G.1
Koskinas, J.2
Kotsiou, S.3
-
37
-
-
77950609492
-
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
-
Lok, A., Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?. Hepatology, 51, 2010, 1109.
-
(2010)
Hepatology
, vol.51
, pp. 1109
-
-
Lok, A.1
-
38
-
-
0036614299
-
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
-
Hsu, Y.S., Chien, R.N., Yeh, C.T., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002), 1522–1527.
-
(2002)
Hepatology
, vol.35
, pp. 1522-1527
-
-
Hsu, Y.S.1
Chien, R.N.2
Yeh, C.T.3
-
39
-
-
77951670101
-
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
-
Chen, J.D., Yang, H.I., Iloeje, U.H., et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138 (2010), 1747–1754.
-
(2010)
Gastroenterology
, vol.138
, pp. 1747-1754
-
-
Chen, J.D.1
Yang, H.I.2
Iloeje, U.H.3
-
40
-
-
73149100612
-
Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study
-
Dutta, A., Saha, C., Johnson, C.S., et al. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study. Hepatology 50 (2009), 1957–1962.
-
(2009)
Hepatology
, vol.50
, pp. 1957-1962
-
-
Dutta, A.1
Saha, C.2
Johnson, C.S.3
-
41
-
-
77951483260
-
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology
-
Lee, J.K., Shim, J.H., Lee, H.C., et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 51 (2010), 1577–1583.
-
(2010)
Hepatology
, vol.51
, pp. 1577-1583
-
-
Lee, J.K.1
Shim, J.H.2
Lee, H.C.3
-
42
-
-
33847701354
-
Chronic hepatitis B
-
Lok, A.S.F., McMahon, B.J., Chronic hepatitis B. Hepatology 45 (2007), 507–539.
-
(2007)
Hepatology
, vol.45
, pp. 507-539
-
-
Lok, A.S.F.1
McMahon, B.J.2
-
43
-
-
34548316975
-
Serum hepatitis B virus-DNA cut-off levels in hepatitis B e antigen-negative chronic hepatitis B virus infection
-
Papatheodoridis, G.V., Manesis, E.K., Manolakopoulos, S., et al. Serum hepatitis B virus-DNA cut-off levels in hepatitis B e antigen-negative chronic hepatitis B virus infection. Hepatology 46 (2007), 606–607.
-
(2007)
Hepatology
, vol.46
, pp. 606-607
-
-
Papatheodoridis, G.V.1
Manesis, E.K.2
Manolakopoulos, S.3
-
44
-
-
77952745777
-
Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase
-
Chu, C.M., Chen, Y.C., Tai, D.I., et al. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase. Clin Gastroenterol Hepatol 8 (2010), 535–540.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 535-540
-
-
Chu, C.M.1
Chen, Y.C.2
Tai, D.I.3
-
45
-
-
61949446214
-
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
-
Dai, C.Y., Chuang, W.L., Huang, J.F., et al. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL. Hepatology 49 (2009), 704–705.
-
(2009)
Hepatology
, vol.49
, pp. 704-705
-
-
Dai, C.Y.1
Chuang, W.L.2
Huang, J.F.3
-
46
-
-
36349010112
-
Hepatitis B virus DNA prediction rules for hepatitis B e antigen negative chronic hepatitis B
-
Feld, J.J., Ayers, M., El-Ashry, D., et al. Hepatitis B virus DNA prediction rules for hepatitis B e antigen negative chronic hepatitis B. Hepatology 46 (2007), 1057–1070.
-
(2007)
Hepatology
, vol.46
, pp. 1057-1070
-
-
Feld, J.J.1
Ayers, M.2
El-Ashry, D.3
-
47
-
-
77955494346
-
Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers
-
Brunetto, M.R., Olivari, F., Colombatto, P., et al. Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 139 (2010), 483–490.
-
(2010)
Gastroenterology
, vol.139
, pp. 483-490
-
-
Brunetto, M.R.1
Olivari, F.2
Colombatto, P.3
-
48
-
-
79959622830
-
Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels
-
Nakazawa, T., Shibuya, A., Takeuchi, A., et al. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels. J Viral Hepat, 2011, 10.1111/j.1365-2893.2010.01427.x.
-
(2011)
J Viral Hepat
-
-
Nakazawa, T.1
Shibuya, A.2
Takeuchi, A.3
-
49
-
-
54449096612
-
Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States
-
Tong, M.J., Hsien, C., Hsu, L., et al. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Hepatology 48 (2008), 1070–1078.
-
(2008)
Hepatology
, vol.48
, pp. 1070-1078
-
-
Tong, M.J.1
Hsien, C.2
Hsu, L.3
-
50
-
-
78751548591
-
Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers
-
Castéra, L., Bernard, P.H., Le Bail, B., et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 33 (2011), 455–465.
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 455-465
-
-
Castéra, L.1
Bernard, P.H.2
Le Bail, B.3
-
51
-
-
12344309018
-
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
-
Castéra, L., Vergniol, J., Foucher, J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005), 343–350.
-
(2005)
Gastroenterology
, vol.128
, pp. 343-350
-
-
Castéra, L.1
Vergniol, J.2
Foucher, J.3
|